Autoclave sterilization of instruments used on women with cervical neoplasia is an effective method of eradicating residual human papillomavirus DNA: A polymerase chain reaction-based evaluation

Journal of Lower Genital Tract Disease

Volumn 11, Issue 1, 2007, Pages 12-17

  Estes, Jacob M ^a   Kirby, Tyler O ^a   Huh, Warner K ^a  

^a University of Alabama   (United States)

Author keywords

Cervical biopsy instruments; Residual HPV DNA; Specula; Sterilization

Indexed keywords

BETA GLOBIN; GLUTARALDEHYDE; VIRUS DNA;

ARTICLE; AUTOCLAVE; BIOPSY DEVICE; BLOTTING; COLPOSCOPY; CONTAMINATION; ERADICATION THERAPY; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; INSTRUMENT; INSTRUMENT STERILIZATION; MEDICAL INSTRUMENTATION; POLYMERASE CHAIN REACTION; UTERINE CERVIX TUMOR; VALIDATION PROCESS; VIRUS TYPING; WART VIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; COLPOSCOPY; DNA, VIRAL; EQUIPMENT CONTAMINATION; FEMALE; GYNECOLOGY; HUMANS; POLYMERASE CHAIN REACTION; STERILIZATION; UTERINE CERVICAL NEOPLASMS;

EID: 33846031972     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.lgt.0000229565.19364.cc     Document Type: Article

References (13)

1. Mounts P, Shah KV. Respiratory papillomatosis: etiologic relation to genital tract papillomaviruses. Prog Med Virol 1984;29:90-114.
2. Ferenczy A, Bergeron C, Richart RM. Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections. Obstet Gynecol 1989;74:950-4.
3. Kreider J, Howett MK, Stoler MH, Zaino RJ, Welsh P. Susceptibility of various tissues to transformation in vivo with human papillomavirus type 11. Int J Cancer 1987;39:459-65.
4. Howley PM. On human papillomaviruses. N Engl J Med 1986;315:1089-90.
5. McCance DJ, Campion MJ, Baram A, Singer A. Risk of transmission of human papillomavirus by vaginal specula. Lancet 1986;2(8510):816-7.
6. Lorincz AT. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J Obstet Gynaecol Res 1996;22:629-36.
7. Gravitt PE, Peyton CL, Alessi QT, Wheeler CM, Coutlee F, Hidelsheim A, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000;38:357-61.
8. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-7.
9. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. ASCCP-Sponsored Consensus Conference. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9.
10. Skegg DCG, Paul C. Viruses, specula, and cervical cancer. Lancet 1986;1(8484):747.
11. Schiffman M, Adrianza ME, ALTS Group. The ASCUS-LSIL Triage Study (ALTS): design, methods, and characteristics of trial participants. Acta Cytol 2000;44:726-42.
12. Kulasingam SL, Kim JJ, Lawrence WF, Mendelblatt JS, Myers ER, Schiffman M, et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). J Natl Cancer Inst 2006;98:92-100.
13. Schiffman M, Wheeler CM, Dasgupta A, Solomon D, Castle PE. A comparison of a prototype PCR assay and Hybrid Capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal Papanicolaou smears. Am J Clin Pathol 2005;124:722-32.